← Back to Clinical Trials
Recruiting Phase 4 NCT06999590

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers

Trial Parameters

Condition Pressure Ulcer
Sponsor Tiger Biosciences, LLC.
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-20
Completion 2027-05
Interventions
ACApatch™caregraFT™Standard of Care

Brief Summary

The purpose of this study it to evaluate several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.

Eligibility Criteria

Inclusion Criteria: 1. The potential subject must be at least 18 years of age or older. 2. The potential subject must agree to attend the weekly study visits required by the protocol. 3. The potential subject must be willing and able to participate in the informed consent process. 4. The potential subject must have a full-thickness pressure ulcer NPIAP stage 3 or stage 4 without exposed tendon or bone of greater than or equal to one month in duration located on the trunk (sacral, trochanteric, or ischial). 5. At enrollment, the potential subject must have a target ulcer with a minimum surface area of 2 cm2 and a maximum surface area of 100 cm2 measured post-debridement with the imaging device. 6. The potential subject has adequate off-loading of the ulcer. Exclusion Criteria: 1. The potential subject is known to have a life expectancy of \< 3 months. 2. The potential subject's target ulcer is not a pressure ulcer. 3. The target ulcer is infected, requires systemic antibiotic therapy, o

Related Trials